Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical is a top performer in the soft-tissue robotics market, with a commanding presence and dominant position worldwide, and is supported by growing value offered to customers that is expected to continue to yield strong top and bottom-line growth. Despite challenges in the US market, the company maintains a solid long-term outlook, making prudent investments in innovation and expanding into new markets, such as China, and has a strong financial position with a high profit margin and steady system placements. These factors, combined with a potential for long-term outperformance, justify a Buy rating for the stock with a target price of $469.

Intuitive Surgical is a leader in the field of robotic surgery with its da Vinci system and a large global presence. However, its recent 2Q26 results have shown softer US da Vinci procedures and limited visibility into upside for the remainder of the fiscal year, which may be indicative of structural headwinds. Additionally, margin compression due to tariff dynamics could impact the company's financial performance in the short term. While the long-term potential of robotic surgery is promising, the current uncertainties do not justify a positive outlook.